Related Experiment Video
Updated: Feb 11, 2026

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma
Published on: June 10, 2017
Extralymphatic Disease Is an Independent Prognostic Factor in Hodgkin Lymphoma
Francesco Gaudio1, Pasquale Pedote2, Artor Niccoli Asabella3
1Hematology Section, Department of Emergency and Organ Transplantation (DETO), University of Bari, Bari, Italy.
Insights
Extralymphatic Hodgkin lymphoma is rare, affecting 16% of patients. This condition is linked to a poorer prognosis and lower complete remission rates compared to traditional lymphatic Hodgkin lymphoma.
Area of Science:
- Hematology
- Oncology
- Clinical Research
Background:
- Hodgkin lymphoma (HL) typically involves lymph nodes.
- Extranodal involvement, or extralymphatic disease, is less common but may impact prognosis.
- Understanding the characteristics of extralymphatic HL is crucial for patient management.
Purpose of the Study:
- To characterize the features of patients diagnosed with extralymphatic Hodgkin lymphoma.
- To evaluate the clinical outcomes and prognostic factors associated with extralymphatic HL.
Main Methods:
- A retrospective analysis was conducted on 341 Hodgkin lymphoma cases.
- Patient data included demographics, disease site, and treatment outcomes.
- Median follow-up was 44 months.
Main Results:
- Extralymphatic disease was identified in 16% (55 out of 341) of patients.
- Common extralymphatic sites included the lung (44%), bone (33%), liver (18%), and kidney (5%).
- Patients with extralymphatic disease showed a poorer prognosis, with complete remission rates of 65% compared to 82% in the lymphatic disease group (P = .043).
Conclusions:
- Extralymphatic Hodgkin lymphoma is an infrequent presentation associated with adverse clinical outcomes.
- The presence of extralymphatic disease signifies a poorer prognosis in Hodgkin lymphoma patients.
- Further research may be warranted to optimize treatment strategies for this subset of patients.
Purpose:
To identify the characteristics and outcomes of patients with extralymphatic Hodgkin lymphoma.
Patients And Methods:
We performed a retrospective single-institution study of 341 cases comprising 207 male (61%) and 134 female (39%) subjects with a median follow-up of 44 months.
Results:
Fifty-five patients (16%) had extralymphatic disease. The sites were lung in 29 patients (44%), bone in 22 (33%), liver in 12 (18%), and kidney in 3 (5%). In 46 patients (86%) only one organ was involved, while in 7 patients (13%) extralymphatic disease was present in 2 sites and in 2 patients (3%) in 3 sites. The extralymphatic disease group had a poorer prognosis than the lymphatic disease group. Complete remission rates in the extralymphatic and lymphatic patient subsets were 65% and 82% (P = .043), respectively.
Conclusion:
Extralymphatic disease in patients with Hodgkin lymphoma is a rare occurrence (16%) associated with poor clinical outcome.
More Related Videos
Related Concept Videos
Introduction to Test of Independence
The test statistic for a test of independence is similar to that of a goodness-of-fit test:
Hypothesis Test for Test of Independence
H0: The two variables (factors)...
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Law of Independent Assortment
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

